Physician profile
Michael Johns
NPI 1730726647
$3,725.02
in general payments reported to CMS, 2019-2025
21 companies · $886 in 2025
The $886 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,126 · 2022: $581 · 2023: $657 · 2024: $476 · 2025: $886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,018.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,878.10 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $373.55 | 2021 | |
| Novo Nordisk INC | $223.96 | 2024-2025 | Wegovy, Ozempic |
| Biohaven Pharmaceutical Holding Company Ltd. | $163.97 | 2022 | |
| Amgen INC. | $151.12 | 2023-2025 | Otezla, Repatha, Repatha |
| Astrazeneca Pharmaceuticals Lp | $144.28 | 2021-2025 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.90 | 2023-2025 | Jardiance, Synjardy |
| Exact Sciences Corporation | $111.28 | 2023-2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $107.55 | 2021 | |
| Nevro Corp. | $92.47 | 2021 | |
| Lilly USA, LLC | $80.68 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $55.88 | 2023-2025 | |
| Inspire Medical Systems, INC. | $34.51 | 2025 | Inspire |
| Nestle Healthcare Nutrition INC. | $28.94 | 2021 | |
| Corium, LLC | $28.29 | 2023 | Azstarys |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $24.00 | 2024 | |
| Jazz Pharmaceuticals INC. | $23.30 | 2021 | |
| Kerecis Limited | $20.78 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Eisai INC. | $19.36 | 2021 | |
| Antares Pharma, INC. | $16.91 | 2023 | Xyosted, Tlando, Nocdurna |
| Ibsa Pharma INC. | $15.19 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Johns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.